# Two StereoTactic Ablative Adaptive Radiotherapy Treatments for Localized Prostate Cancer

> **NCT02031328** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Sunnybrook Health Sciences Centre** · enrollment: 30 (estimated)

## Conditions studied

- Prostate Adenocarcinoma

## Interventions

- **RADIATION:** Stereotactic Ablative Radiation

## Key facts

- **NCT ID:** NCT02031328
- **Lead sponsor:** Sunnybrook Health Sciences Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-01
- **Primary completion:** 2014-09-12
- **Final completion:** 2024-09-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2020-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02031328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02031328, "Two StereoTactic Ablative Adaptive Radiotherapy Treatments for Localized Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02031328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*